Reaction Details |
| Report a problem with these data |
Target | Gastrin/cholecystokinin type B receptor |
---|
Ligand | BDBM50410564 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_321686 (CHEMBL872181) |
---|
IC50 | 11±n/a nM |
---|
Citation | Buck, IM; Black, JW; Cooke, T; Dunstone, DJ; Gaffen, JD; Griffin, EP; Harper, EA; Hull, RA; Kalindjian, SB; Lilley, EJ; Linney, ID; Low, CM; McDonald, IM; Pether, MJ; Roberts, SP; Shankley, NP; Shaxted, ME; Steel, KI; Sykes, DA; Tozer, MJ; Watt, GF; Walker, MK; Wright, L; Wright, PT Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists. J Med Chem48:6803-12 (2005) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Gastrin/cholecystokinin type B receptor |
---|
Name: | Gastrin/cholecystokinin type B receptor |
Synonyms: | CCKBR | Cholecystokinin B | Cholecystokinin B receptor | GASR_CANLF | Gastrin/cholecystokinin type B receptor |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 48544.19 |
Organism: | Dog |
Description: | Cholecystokinin B 0 Dog::P30552 |
Residue: | 453 |
Sequence: | MELLKLNRSAQGSGAGPGASLCRAGGALLNSSGAGNLSCEPPRLRGAGTRELELAIRVTL
YAVIFLMSVGGNVLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTF
IFGTVVCKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIIATWM
LSGLLMVPYPVYTAVQPAGGARALQCVHRWPSARVRQTWSVLLLLLLFFVPGVVMAVAYG
LISRELYLGLRFDEDSDSESRVRSQGGLRGGAGPGPAPPNGSCRPEGGLAGEDGDGCYVQ
LPRSRQTLELSALTAPTPGPGGGPRPYQAKLLAKKRVVRMLLVIVVLFFLCWLPLYSANT
WRAFDSSGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPR
ARPRPLPDEDPPTPSIASLSRLSYTTISTLGPG
|
|
|
BDBM50410564 |
---|
n/a |
---|
Name | BDBM50410564 |
Synonyms: | CHEMBL425574 |
Type | Small organic molecule |
Emp. Form. | C31H41N3O3 |
Mol. Mass. | 503.6755 |
SMILES | Cc1ccc(NC(=O)c2[nH]c(nc2CCC23CC4CC(CC(C4)C2)C3)C2(C)CCCCC2)cc1C(O)=O |TLB:22:17:24:21.23.20,22:21:24:17.16.18,18:19:23:17.16.22,THB:18:17:23:19.24.20,20:19:16:21.23.22,20:21:16:19.24.18| |
Structure |
|